A strategic leader and one of Australia’s most highly awarded computational scientists, whose research in high performance supercomputing, applied machine learning and artificial intelligence spans nanoscience, materials, engineering, chemistry and health. With more than 20 years’ experience, she is deeply engaged in international science diplomacy and research governance, and in 2022 was appointed a Member of the Order of Australia for significant service to science and the community.

Senior healthcare investor with over 30 years of experience across clinical medicine, investment banking, and hospital management. Former CEO of the China Division of IHH Healthcare, and former Chairman and CEO of Tian An Medicare. Previously also at Merrill Lynch Investment Banking, Biotronik, and as a physician at Singapore National University Hospital. He has a medical degree from the Royal College of Surgeons in Dublin and is a Harvard Business School MBA. He is currently also a venture partner, adviser and director of Sanara Capital, Sabai Health AI, and LifeClinic HK respectively.